# Interferon Alfa in Treating Children With HIV-Related Cancer

> **NCT00002621** · PHASE2 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 8 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** recombinant interferon alfa

## Key facts

- **NCT ID:** NCT00002621
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-12
- **Primary completion:** 2002-07
- **Final completion:** 2005-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002621, "Interferon Alfa in Treating Children With HIV-Related Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00002621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*